Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
The New Republic on MSN3hOpinion
Dr. Oz Has Some Pretty Shady Conflicts of InterestTrump’s pick to run Medicare and Medicaid is involved with a number of businesses that are involved with both.
Since 2018, Ozempic's net price has fallen from $531 to $290, or 45%. Since 2020, Rybelsus' net price has dropped from $376 to $296, or 21%. In contrast, Wegovy's net price has increased 21% since ...
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...
Dr. Oz has extolled Ozempic’s promise for weight-loss. Now Medicare, which Trump wants Oz to oversee, may cover it.
After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets ...
The New Republic on MSN1hOpinion
Trump’s Press Secretary Once Opposed Election DenialismKaroline Leavitt, who Donald Trump has chosen as his White House press secretary, once criticized the Capitol insurrection ...
Raw Story on MSN9h
'Whoa! Now we’re talking!' Expert warns Dr. Oz threatens Trump with 'ethical morass'Donald Trump’s pick of TV doctor Mehmet Oz threatens to bring an “ethical morass” to an administration already packed with ...
As usual, the president thinks bellicose threats of force—very much including setting off a regional war with Iran—are the ...
We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback